Skip to main content
OpenTrials

Clinical trial condition

ALK-positive Advanced Tumors

Explore clinical trials studying ALK-positive Advanced Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

ALK-positive Advanced Tumors trial results

Completed

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

NCT02422589

Conditions
ALK-positive Advanced Tumors
Locations
  • Karmanos Cancer Institute Oncology Department Detroit, Michigan, United States
  • Henry Ford Hospital SC Detroit, Michigan, United States
  • Cancer Therapy & Research Center UT Health Science Center SC-4 San Antonio, Texas, United States
  • Novartis Investigative Site Copenhagen, Denmark
View Trial Details